M&A Healthcare Advisors Brokers Innovo Detox Sale to R&S Holdings
MAHA facilitated the acquisition of Pennsylvania-based Innovo Detox, a substance use disorder treatment provider, by R&S Holdings, Inc.
M&A Healthcare Advisors (MAHA), a FINRA-licensed investment bank specializing in healthcare transactions, announced Monday the completed sale of Innovo Detox to R&S Holdings, Inc., expanding the acquirer's footprint in the behavioral health sector.
Innovo Detox, headquartered in Pennsylvania, provides substance use disorder treatment and related drug and alcohol recovery services. The transaction adds a specialized clinical operation to R&S Holdings' portfolio at a time when demand for SUD treatment services remains elevated across the country.
Read more Dilworth Paxson Adds Insurance Team to New York Office →
MAHA served as the exclusive financial advisor to Innovo Detox in the deal, leveraging its focus on healthcare industry mergers and acquisitions. The firm is registered with FINRA, underscoring the regulated nature of the advisory role it plays in facilitating such transactions.
The behavioral health and addiction treatment space has attracted sustained investor interest in recent years, driven by persistent demand for SUD services and a fragmented provider landscape that creates consolidation opportunities. Transactions like this one reflect broader market dynamics pushing regional operators toward strategic partnerships or outright sales.
Terms of the deal were not disclosed. Continue reading at All Financial Services & Investing.
